MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$9,025,779
Net Income
$724,192
Net Profit Margin
8.02%
EPS
$0.003
Unit: Dollar
Revenue Breakdown
Sale Of Pharmaceutical Products ...
Other Revenue
Revenue Breakdown
gross profit
cost of goods sold
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
9,025,779
9,582,886.5*
8,386,779
9,050,626
Cost of goods sold
2,750,510
3,735,939*
1,987,769
2,326,643
Gross profit
6,275,269
5,846,947.5*
6,399,010
6,723,984
Salaries expense
3,217,201
3,485,736.75*
2,931,244
4,049,998
Selling general and administrative expenses
1,050,032
867,662*
914,029
888,495
Bank charges
262,906
255,030*
250,332
-
Advertising & marketing
850,004
667,747.5*
708,511
740,026
Bank charges
-
-
-
219,667
Legal and professional fees
131,912
119,408.5*
56,022
11,825
Insurance
33,571
44,496.5*
40,318
42,253
Operating lease cost
45,043
45,188.25*
-
-
Depreciation and amortization
66,861
-119,825.5*
121,790
147,691
Utilities
39,938
16,556*
34,743
41,413
Total expenses
5,697,468
5,382,000*
5,056,988
6,141,366
Dividend income
-
-
-
6,956
Dividend and interest income
2,824
1,847*
4,537
-
Interest earned
-
-
457
1,799
Net realized loss on sale of investments
365,537
-11,519.5*
309,807
145,558
Unrealized gain on fair value changes of investments
19,374
-361,045*
-613,741
216,359
Other
9,013
16,798.5*
-
-
Interest expense
16,197
-1,916*
4,769
7,393
Net income before taxes
958,352
112,944.5*
1,038,314
945,897
Income taxes
242,655
-703,596.5*
127,946
-
Net income
715,697
816,541*
910,367
945,897
Net gain attributed to non-controlling interest
-8,495
1,563.5*
-9
-20,926
Net income available to common stockholders
724,192
814,977.5
910,376
966,823
Basic EPS
0.003
0.003
0.003
0.003
Diluted EPS
0.003
0.003
0.003
0.003
Basic Average Shares
290,000,679
293,335,439
292,804,167
-
Diluted Average Shares
290,000,679
293,335,439
292,804,167
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Sale Of
Pharmaceutical Products And...
$8,994,351
Other Revenue
$31,428
Revenue
$9,025,779
Gross profit
$6,275,269
Net realized loss on
sale of investments
$365,537
Unrealized gain on fair
value changes of...
$19,374
Cost of goods sold
$2,750,510
Other
$9,013
Dividend and interest
income
$2,824
Net income before
taxes
$958,352
Total expenses
$5,697,468
Interest expense
$16,197
Net income
$715,697
Net gain attributed
to...
-$8,495
Income taxes
$242,655
Salaries expense
$3,217,201
Selling general and
administrative expenses
$1,050,032
Advertising & marketing
$850,004
Bank charges
$262,906
Legal and
professional fees
$131,912
Depreciation and
amortization
$66,861
Operating lease cost
$45,043
Utilities
$39,938
Insurance
$33,571
Net income
available to common...
$724,192
Buy us a coffee
Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (ETST)